Clinical Trial Update: A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis [Phase 1, Phase 2]

View source ↗

Summary

Pilot study evaluating sirolimus (mTOR inhibitor) in children and young adults with desmoid-type fibromatosis completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid Tumor

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: MaineHealth | Conditions: Desmoid Tumor | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-06-26